Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
| Autor: | Matthews, David R *, Paldánius, Päivi M, Proot, Pieter, Chiang, YannTong, Stumvoll, Michael, Del Prato, Stefano |
|---|---|
| Zdroj: | In The Lancet 26 October-1 November 2019 394(10208):1519-1529 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|